Gingival enlargement in antihypertensive medication

Journal of the Nepal Medical Association

Volumn 48, Issue 174, 2009, Pages 149-152

  Pradhan, Shaili ^a   Mishra, P ^a  

^a BIR HOSPITAL   (Nepal)

Author keywords

Anti hypertensive drugs; Gingival enlargement

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; DISEASE SEVERITY; DRUG EFFECT; DRUG USE; GINGIVA DISEASE; GINGIVAL ENLARGEMENT; GINGIVITIS; HUMAN; MAJOR CLINICAL STUDY; MOUTH HYGIENE; PERIODONTAL EXAMINATION; RISK ASSESSMENT; TOOTH PLAQUE;

EID: 74849118592     PISSN: 00282715     EISSN: None     Source Type: Journal    
DOI: 10.31729/jnma.232     Document Type: Article

References (31)

1. Angelopoulos AP. Diphenylhydantoin gingival hyperplasia. A clinicopathological review. 1. Incidence, clinical features and histopathology. Dent J. 1975 Feb;41(2):103-6.
2. Seymour RA, Jacobs DJ. Cyclosporin and the gingival tissues. J Clin Periodontol. 1992 Jan;19(1):1-11.
3. Rateitschak-Plüss EM, Hefti A, Lörtscher R, Thiel G. Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Periodontol 1983;10(3):237-46.
4. Calne RY, Rolles K, White DJ, et al. Cyclosporine A in clinical organ grafting. Transplant Proc. 1981;13:349-58.
5. Seymour RA. Calcium channel blockers and gingival overgrowth. Br Dent J. 1991;170:376.
6. Kimball OP. The treatment of epilepsy with sodium diphenyl hydantoinate. J Am Med Assoc. 1939;112:1244-5
7. Brunet L, Miranda J, Farré M, Berini L, Mendieta C. Gingival enlargement induced by drugs. Drug Saf. 1996 Sep;15(3):219-31.
8. Dukes MG, Aronson JK. Myler's Side Effects of Drugs: An Encyclopedia of Adverse Reactions and Interactions. 40th ed. New York: Elsevier; 2000.
9. Lederman D, Lumerman H, Reuben S, Freedman PD. Gingival hyperplasia associated with nifedipine therapy. Report of a case. Oral Surg Oral Med Oral Pathol. 1984 Jun;57(6):620-2.
10. Ramon Y, Behar S, Kishon Y, Engelberg IS. Gingival hyperplasia caused by nifedipine - a preliminary report. Int J Cardiol. 1984 Feb;5(2):195-206.
11. Lucas RM, Howell LP, Wall BA. Nifedipine-induced gingival hyperplasia. A histochemical and ultrastructural study.J Periodontol. 1985 Apr;56(4):211-5.
12. Bullon P, Machuca G, Martinez-Sahuquillo A, Rios JV, Rojas J, Lacalle JR. Clinical assessment of gingival hyperplasia in patients treated with nifedipine. J Clin Periodontol. 1994 Apr;21(4):256-9.
13. Miranda J, Brunet L, Roset P, Berini L, Farré M, Mendieta C. Prevalence and risk of gingival enlargement in patients treated with nifedipine. J Periodontol. 2001 May;72(5):605-11.
14. Brown RS, Sein P, Corio R, Bottomley WK. Nitrendipine-induced gingival hyperplasia. First case report. Oral Surg Oral Med Oral Pathol. 1990 Nov;70(5):593-6.
15. Nagano S, Ogawa T, Fukuyama S. Infl uence of nicardipine hydrochlorhide on hypotensive effect and insulin secretion in a patient of hypertensive diabetic mellitus. Japan Pharmacol Therapeut. 1985;19:5309-13.
16. Lombardi T, Fiore-Donno G, Belser U, Di Felice R. Felodipine-induced gingival hyperplasia: a clinical and histologic study. J Oral Pathol Med. 1991 Feb;20(2):89-92.
17. Seymour RA, Ellis JS, Thomason JM, Monkman S, Idle JR. Amlodipine-induced gingival overgrowth. J Clin Periodontol. 1994 Apr;21(4):281-3.
18. Quigley GA, Hein JW. Comparative classifying efficiency of normal and power brushing. J Am Dent Assoc. 1962;65:26-9.
19. Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM. Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study. J Periodontol. 1999 Jan;70(1):63-7.
20. Nery EB, Edson RG, Lee KK, Pruthi VK, Watson J. Prevalence of nifedipine-induced gingival hyperplasia. J Periodontol. 1995 Jul;66(7):572-8.
21. Seymour RA, Ellis JS, Thomason JM. Risk factors for druginduced gingival overgrowth. J Clin Periodontol. 2000 Apr;27(4):217-23.
22. Pernu HE, Oikarinen K, Hietanen J, Knuuttila M. Verapamil-induced gingival overgrowth: a clinical, histologic, and biochemic approach. J Oral Pathol Med. 1989 Aug;18(7):422-5.
23. Nyska A, Waner T, Pirak M, Galiano A, Zlotogorski A. Gingival hyperplasia in rats induced by oxodipine - a calcium channel blocker. J Periodontal Res. 1990 Mar;25(2):65-8.
24. Puolijoki H, Siitonen L, Saha H, Suojanen I. Gingival hyperplasia caused by nifedipine. Proc Finn Dent Soc. 1988;84(5-6):311-4.
25. Mohapatra BN, Kar BC, Das P. Nifedipine-induced gum hyperplasia. J Assoc Physicians India. 1991 Jun;39(6):506.
26. Bhatia RS. Nifedipine induced reversible gingival hyperplasia. J Assoc Physicians India. 1992 Jul;40(7):486.
27. James JA, Linden GJ. Nifedipine induced gingival hyperplasia. Dental Update. 1992;19:440-1.
28. Nishikawa S, Tada H, Hamasaki A, Kasahara S, Kido J, Nagata T, et al. Nifedipine induced gingival hyperplasia : a clinical and in vitro study. J Periodontol. 1991;62:30-5.
29. Mavrogiannis M, Ellis JS, Thomason JM, Seymour RA. The management of drug-induced gingival overgrowth. J Clin Periodontol. 2006;33:434-9.
30. Raman PG, Mishra VN, Singh D. Nifedipine induced gingival hyperplasia. J Assoc Physicians India. 1988;36:231-3.
31. Seymour RA, Smith DG. The effect of plaque control programme on the incidence and severity of cyclosporine-induced gingival changes. J Clin Periodontol. 1991;18:107-10.